First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTResearch in Context

Summary: Background: The DynamX™ bioadaptor is the first coronary implant technology with a unique mechanism of unlocking the bioadaptor frame after polymer resorption over 6 months, uncaging the vessel while maintaining a dynamic support to the vessel. It aims to achieve the acute performance of d...

詳細記述

書誌詳細

主要な著者:	Shigeru Saito, Johan Bennett, Holger M. Nef, Mark Webster, Atsuo Namiki, Akihiko Takahashi, Tsunekazu Kakuta, Seiji Yamazaki, Yoshisato Shibata, Douglas Scott, Mathias Vrolix, Madhav Menon, Helge Möllmann, Nikos Werner, Antoinette Neylon, Zlatko Mehmedbegovic, Pieter C. Smits, Marie-Claude Morice, Stefan Verheye
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2023-11-01
シリーズ:	EClinicalMedicine
主題:	Bioadaptor Percutaneous coronary intervention Coronary artery disease Drug-eluting stents Cyclic pulsatility Vessel function
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2589537023004819
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!